Real-time enrollment status for this macular degeneration clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 4:23 AM UTC
| NCT Number | NCT06805474 |
| Recruiting Status | Recruiting |
| Condition | Macular Degeneration |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Nanoscope Therapeutics Inc. |
| Last Updated on CT.gov | March 24, 2025 (Mar 24, 2025) |
As of July 17, 2026: Clinical trial NCT06805474 is currently recruiting participants. This clinical trial study for macular degeneration is actively seeking new participants at 1 location across the United States. The study is sponsored by Nanoscope Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06805474 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06805474 was last updated Mar 24, 2025 (March 24, 2025). HelloStudys verifies this status automatically.